Clinicians Back Soligenix's HyBryte™ for Cutaneous T-Cell Lymphoma; PCG Interview Dr. Brian Poligone

(11:31)

Soligenix; Cutaneous Lymphoma Foundation CEO Susan Thornton on HyBryte™

(2:10)

Soligenix; Discussing Cutaneous Lymphoma with Foundation CEO Susan Thornton

(14:36)

Soligenix - U.S. Commercialization of SGX301 in the Treatment of Cutaneous T-Cell Lymphoma

(1:48:27)

Soligenix: Public Health Solutions and Treatments for Unmet Medical Needs

(31)

Soligenix; Announcing New FDA Drug Application Submission for Cutaneous T-cell Lymphoma

(5:37)

Polynucleotides vs. Sunekos vs. Profhilo: Which Skin Treatment is Right for You?

(3:26)

Lichen Sclerosus - How I finally accomplished remission

(9:34)

Sugar Sag? Glycation+Solar Elastosis | Copper peptide info | Dryness and microneedling

(16:58)

Moxi™ by Sciton | Prejuvenation for Younger-Looking Skin

(2:52)

Lichen Sclerosus Diagnosis - Autoimmune Skin Disorder

(3:20)

\

(8:55)

What are the different types of acne?

(2:25)

Soligenix; Diving Deeper Into The Company Itself

(8:25)

Windyigarn Spicule BioMicroneedling Kit Day 3 - Amazing Results by Nature

(2:16)

Skin Biopsy Detection of Phosphorylated α-Synuclein

(22:18)

Revolutionizing Rare Disease Treatment: Soligenix's Breakthroughs

(6:31)

Soligenix: Rising to the Challenges of Rare Disease Treatment

(3:16)

Soligenix; Discussing the Benefits of HyBryte™ CTCL Treatment with Michael W. Young

(13:31)

Learn Why Soligenix Has Recieved Over $60M in NIH and Other Government Grants

(31)

Soligenix; Discussing Psoriasis Treatment with Dr. Neal Bhatia

(6:47)

Soligenix: A Late-Stage Biopharma Pioneer Tackling Rare Diseases with Unmet Needs

(23)

Soligenix: Developing \u0026 Commercializing Treatments for Rare Diseases with Unmet Needs

(2:6)

Soligenix HyBryte

(1:39)

Soligenix Updates on Heat-Stable Vaccines and Oncology Advances

(6:45)

Cutaneous T-Cell Lymphoma and SGX301

(3:19)

Unlocking Health Innovations: Soligenix's (NASDAQ:SNGX) Breakthrough Therapies for Rare Diseases

(7:55)

Soligenix (NASDAQ: SNGX) : Revolutionizes Rare Disease Treatment \u0026 Advances Groundbreaking Vaccines

(1:45)

Soligenix Investor Overview

(2:8)

Soligenix; Diving into HyBryte CTCL Treatment Efficacy and Safety with Dr. Jennifer DeSimone

(7:49)